Literature DB >> 20214655

Multifuntional nanoparticles: preparation and applications in biomedicine and in non-invasive bioimaging.

Andrea Masotti1.   

Abstract

In recent years, polymeric scaffolds have been used in several biomedical applications for the delivery of drugs or other biologically relevant molecules. Polymeric nanostructures possess different (and in some cases more powerful) properties respect to bulk materials. This, leaded academic researchers and industry to cooperate in developing pioneering nanostructured materials for industrial and biomedical applications. Moreover, the preparation and use of systems with multiple (multifunctional) properties (i.e., bioconjugation with superparamagnetic, fluorescent or targeting molecules) will represent in the future a viable and innovative tool for application in several clinical fields. This brief critical review collects and discusses some recent patents about the preparation and use of these multifunctional nanoparticles in biomedicine and in non-invasive bioimaging applications.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20214655     DOI: 10.2174/187221010790712093

Source DB:  PubMed          Journal:  Recent Pat Nanotechnol        ISSN: 1872-2105            Impact factor:   1.952


  3 in total

Review 1.  Targeted imaging and therapy of brain cancer using theranostic nanoparticles.

Authors:  Mahaveer Swaroop Bhojani; Marcian Van Dort; Alnawaz Rehemtulla; Brian D Ross
Journal:  Mol Pharm       Date:  2010-10-27       Impact factor: 4.939

2.  A Multimodal Nanocomposite for Biomedical Imaging.

Authors:  Aiguo Wu; Tatjana Paunesku; Zhuoli Zhang; Stefan Vogt; Barry Lai; Jörg Maser; Vahid Yaghmai; Debiao Li; Reed A Omary; Gayle E Woloschak
Journal:  AIP Conf Proc       Date:  2011-09-09

3.  Programmable nanoparticle functionalization for in vivo targeting.

Authors:  Hua Pan; Jacob W Myerson; Lingzhi Hu; Jon N Marsh; Kirk Hou; Michael J Scott; John S Allen; Grace Hu; Susana San Roman; Gregory M Lanza; Robert D Schreiber; Paul H Schlesinger; Samuel A Wickline
Journal:  FASEB J       Date:  2012-10-09       Impact factor: 5.191

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.